Notice2024-04060
Government-Owned Inventions; Availability for Licensing
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
February 28, 2024
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Abstract
The invention listed below is owned by an agency of the U.S. Government and is available for licensing to achieve expeditious commercialization of results of federally-funded research and development. Foreign patent applications are filed on selected inventions to extend market coverage for companies and may also be available for licensing.
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 40 (Wednesday, February 28, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 40 (Wednesday, February 28, 2024)]
[Notices]
[Page 14670]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-04060]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Government-Owned Inventions; Availability for Licensing
AGENCY: National Institutes of Health, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: The invention listed below is owned by an agency of the U.S.
Government and is available for licensing to achieve expeditious
commercialization of results of federally-funded research and
development. Foreign patent applications are filed on selected
inventions to extend market coverage for companies and may also be
available for licensing.
FOR FURTHER INFORMATION CONTACT: Wade Green at (301) 761-7505 or
<a href="/cdn-cgi/l/email-protection#a3c4d1c6c6cdd4d4e3cdcacb8dc4ccd5"><span class="__cf_email__" data-cfemail="e2859087878c9595a28c8b8acc858d94">[email protected]</span></a>. Licensing information may be obtained by communicating
with the Technology Transfer and Intellectual Property Office, National
Institute of Allergy and Infectious Diseases, 5601 Fishers Lane,
Rockville, MD 20852: tel. 301-496-2644. A signed Confidential
Disclosure Agreement will be required to receive copies of unpublished
information related to the invention.
SUPPLEMENTARY INFORMATION: Technology description follows:
An Innovative Adapter for Expedited and Automated Thawing of viably
Frozen Cells.
Description of Technology
This technology is a device and system for expediting the thawing
frozen specimens (e.g., cryopreserved cells) contained in cryo-vials,
offering a breakthrough solution for researchers seeking efficiency and
precision in their workflows. The device is equipped with a small
elongated tubular adaptor that suspends a cryo-vial of frozen cells
over a centrifuge tube containing culture medium in an inverted
position. With a focus on speed, efficiency and automation, the adaptor
dramatically expedites the process of recovering viable cells from
frozen specimens. It reduces per-sample labor time for thawing from
several minutes to a few seconds, enabling a single technician to
simultaneously thaw multiple vials within the capacity of centrifuges.
The cells, once thawed, are diluted instantly into growth medium
contained in the centrifuge tubes and spend essentially no time in
liquid cryopreservative.
The automated mechanism ensures a precise and controlled thawing
environment maintaining optimal temperature conditions throughout the
thawing process.
Potential Commercial Applications:
<bullet> This device can be used in sample preparation and cell
culturing.
<bullet> Applicable for research materials, medical and non-medical
devices and consumer products.
Competitive Advantages:
<bullet> Provides a faster process of recovering viable cells from
frozen specimens.
<bullet> Eliminates multi-step processes.
<bullet> High throughput system with reduced variability.
<bullet> Constant environment control.
Development Stage:
<bullet> Prototype
Inventors: Dr. Mario Roederer, Dr. Pratip Chattopadhyay and
Margaret Beddall, all of NIAID.
Publications: n/a.
Intellectual Property: HHS Reference No. E-080-2015-0-EIR-00 U.S.
Patent Application No. 14/661,449, filed on March 18, 2015; Published
Patent Application US20160274004A1 on September 22, 2016; U.S. Patent
9,663,812 issued May 30, 2017.
Licensing Contact: To license this technology, please contact Wade
Green at (301) 761-7505 or <a href="/cdn-cgi/l/email-protection#a4c3d6c1c1cad3d3e4cacdcc8ac3cbd2"><span class="__cf_email__" data-cfemail="167164737378616156787f7e38717960">[email protected]</span></a>. and reference E-080-2015.
Collaborative Research Opportunity: The National Institute of
Allergy and Infectious Diseases is seeking statements of capability or
interest from parties interested in collaborative research to further
develop, evaluate, or commercialize this technology. For collaboration
opportunities, please contact Wade Green at (301) 761-7505 or
<a href="/cdn-cgi/l/email-protection#bed9ccdbdbd0c9c9fed0d7d690d9d1c8"><span class="__cf_email__" data-cfemail="ed8a9f8888839a9aad838485c38a829b">[email protected]</span></a>.
Dated: February 7, 2024.
Surekha Vathyam,
Deputy Director, Technology Transfer and Intellectual Property Office,
National Institute of Allergy and Infectious Diseases.
[FR Doc. 2024-04060 Filed 2-27-24; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on February 28, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.